File Download

There are no files associated with this item.

Conference Paper: Bringing new drugs to the Chinese marketplace: The corporatization of academic research and the commodification of drug discovery in Hong Kong

TitleBringing new drugs to the Chinese marketplace: The corporatization of academic research and the commodification of drug discovery in Hong Kong
Authors
Issue Date2017
Citation
The 25th International Congress of History of Science and Technology How to Cite?
AbstractThe Chinese pharmaceutical business is a lucrative market force for not only global pharmaceutical companies but also academic biologists and clinical-trial researchers who serve as mediators between producers and consumers of new drugs. In Hong Kong, the changing governance of public universities towards privatization and corporatization has prompted academic researchers to generate income through engaging in entrepreneurial activities. The universities’ quest for becoming entrepreneurial create a strong push for academic life scientists to create linkage with drug manufacturers and consumer markets. Academic biologists have become a crucial actor in drug discovery and development, not only as researchers for conducting laboratory research and clinical trials, but also as salesmen and developers through participating in a number of non-research activities that help pharmaceutical companies to identify and create new markets.
Persistent Identifierhttp://hdl.handle.net/10722/243665

 

DC FieldValueLanguage
dc.contributor.authorLuk, YLC-
dc.date.accessioned2017-08-25T02:57:58Z-
dc.date.available2017-08-25T02:57:58Z-
dc.date.issued2017-
dc.identifier.citationThe 25th International Congress of History of Science and Technology-
dc.identifier.urihttp://hdl.handle.net/10722/243665-
dc.description.abstractThe Chinese pharmaceutical business is a lucrative market force for not only global pharmaceutical companies but also academic biologists and clinical-trial researchers who serve as mediators between producers and consumers of new drugs. In Hong Kong, the changing governance of public universities towards privatization and corporatization has prompted academic researchers to generate income through engaging in entrepreneurial activities. The universities’ quest for becoming entrepreneurial create a strong push for academic life scientists to create linkage with drug manufacturers and consumer markets. Academic biologists have become a crucial actor in drug discovery and development, not only as researchers for conducting laboratory research and clinical trials, but also as salesmen and developers through participating in a number of non-research activities that help pharmaceutical companies to identify and create new markets.-
dc.languageeng-
dc.relation.ispartofThe 25th International Congress of History of Science and Technology-
dc.titleBringing new drugs to the Chinese marketplace: The corporatization of academic research and the commodification of drug discovery in Hong Kong -
dc.typeConference_Paper-
dc.identifier.emailLuk, YLC: chrisluk@hku.hk-
dc.identifier.authorityLuk, YLC=rp02136-
dc.identifier.hkuros275248-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats